Summary
Boston Scientific Corporation (BSX) filed an 8-K on November 15, 2004, to report amendments to its credit facilities. The company increased its borrowing capacity under its $1,500 million revolving credit facility by $123.75 million and its $500 million 364-day revolving credit facility by $41.25 million. These enhancements to the company's credit lines, effective November 11, 2004, provide greater financial flexibility and support its commercial paper program. These increases demonstrate Boston Scientific's proactive approach to managing its liquidity and financial resources. The unrestricted use of these borrowings suggests they are intended to support ongoing operations, potential investments, or strategic initiatives. Investors should view this as a positive development, indicating the company's ability to access capital to fund its growth and operational needs.
Key Highlights
- 1Boston Scientific amended its existing credit facilities on November 11, 2004.
- 2The $1,500 million revolving credit facility's borrowing capacity was increased by $123,750,000.
- 3The $500 million 364-day revolving credit facility's borrowing capacity was increased by $41,250,000.
- 4The total increase in borrowing capacity across both facilities is $165,000,000.
- 5These credit facilities support the company's commercial paper program.
- 6The borrowings under these facilities are unsecured and their use is unrestricted.